
Mexigliz M 60mg/500mg Tablet XR
Marketer
Fugo Life Science Pvt Ltd
Salt Composition
Gliclazide (60mg) + Metformin (500mg)
Overview Mexigliz M 60mg/500mg Tablet XR
Diabexe Duo 60mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of Mexigliz M 60mg/500mg Tablet XR
No text provided. Please provide the text you wish me to rephrase.
Uses of Mexigliz M 60mg/500mg Tablet XR
Non-insulin-dependent diabetes
Major Benefits of Mexigliz M 60mg/500mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Mexigliz M 60mg/500mg Extended-Release tablet should be taken with a meal.
Common Side effects of Mexigliz M 60mg/500mg Tablet XR:
- Hypoglycemia (low blood glucose level)
- Headache
- Dizziness
- Diarrhea
- Upper respiratory tract infection
- Nausea
- Flatulence
- Constipation
How to use Mexigliz M 60mg/500mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mexigliz M 60mg/500mg Extended-Release tablet should be taken with a meal.
How Mexigliz M 60mg/500mg Tablet XR works:
Extended-release Mexigliz M tablets (60mg/500mg) contain a dual-action formulation of gliclazide and metformin, both used in diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mexigliz M 60mg/500mg XR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mexigliz M 60mg/500mg tablets pose a confirmed risk to fetal development and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mexigliz M 60mg/500mg tablets are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Mexigliz M 60mg/500mg XR tablets. Dosage modification may be necessary; physician consultation is advised. Mexigliz M 60mg/500mg XR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Mexigliz M 60mg/500mg Extended-Release tablets cautiously. Dosage modification of Mexigliz M 60mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised. A low starting dose of Mexigliz M 60mg/500mg Extended-Release tablets is typically employed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Mexigliz M 60mg/500mg Tablet XR :
Should you forget to take a Mexigliz M 60mg/500mg extended-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mexigliz M 60mg/500mg Tablet XR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Treatment | Diabetes Medication |
